Pharmacy ownership was once again a key aspect of McKesson ideaShare, as McKesson hosted its sixth annual RxOwnership program on June 29 to help advise independent pharmacy operators that are looking to buy or sell an existing store.
Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.
A nonprofit pharmacy advocacy group has launched a new project that it said was aimed at ensuring fair audit standards for prescription drug claims paid under the Medicare Part D program and protecting pharmacies and patients from what it called unfair audit and conduct practices by pharmacy benefit managers.
The Food and Drug Administration has made a significant dent in its large backlog of generic drug applications thanks to amendments to last year's reauthorization of the Prescription Drug User Fee Act, the agency said.
With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.
Amid mounting evidence of the negative clinical and economic consequences of medication nonadherence, research featured on the cover of this month’s Health Affairs breaks new ground by urging innovative approaches to improve medication adherence and to “achieve a higher-performing health system.”
Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.
One of the most effective levers pharmacists and other health professionals can pull to curb the nation’s $2.7 trillion health care bill is boosting patients’ adherence to their prescription drug treatment regimens. But who’s holding the handle?
Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.
CVS Caremark has released the “2013 State of States: Adherence Report,” which reviews how patients in all 50 states are, or are not, taking their medications as directed by their doctors.
This is important as medication nonadherence continues to be a significant issue within the U.S. healthcare system. To be more specific, medication nonadherence in the U.S. accounts for up to $290 billion in excess healthcare costs annually. Yes, billion.
CVS/pharmacy has bolstered its mobile app by adding the new Drug Interaction Checker, which is an industry first that allows customers to easily check for potential drug interactions by comparing OTC products with their prescriptions and other OTCs on their smartphones.